Ocean Biomedical Newsroom

Ocean Biomedical Receives Nasdaq Non-Compliance Notice For Minimum Bid Price

BenzingaDec 9 16:37 ET

10-K: FY2023 Annual Report

SECNov 25 17:32 ET · Announcements

Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report

BenzingaNov 22 16:52 ET

12 Health Care Stocks Moving In Thursday's After-Market Session

BenzingaOct 31 16:34 ET

Express News | Ocean Biomedical Inc - Elizabeth Ng to Take a Sabbatical for Personal Reason

ReutersOct 29 16:47 ET

Express News | Ocean Biomedical Inc - Michelle Berrey to Act as Interim Chief Executive Officer

ReutersOct 29 16:46 ET

Express News | Ocean Biomedical- Ownership in Virion to Equal 22% of Virion's Issued & Outstanding Membership Interests, in Exchange for $9 Mln

ReutersOct 17 17:10 ET

Express News | Ocean Biomedical- Ratified Fully Countersigned Copy of Revised Agreement With Virion Therapeutics Received on Sept 26

ReutersOct 17 17:08 ET

Ocean Biomedical, Molecure Sign Licensing Agreement for YKL-40 Inhibitors

TipRanksOct 15 07:40 ET

Molecure (WSE: MOC) and Nasdaq-listed Biotechnology Company Ocean Biomedical (NASDAQ: OCEA) Sign an Exclusive Licensing Agreement for the Development and Commercialization of Selective YKL-40 Inhibitors.

GlobeNewswireOct 15 07:30 ET

Ocean Biomedical's Oncology Platform Included in New Published Study

TipRanksOct 1 08:11 ET

Ocean Biomedical Announces Publication Of New Data Deepening Understanding Of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 And Its Ability To Inhibit Anti-Tumor And Related Tissue Remodeling Responses

BenzingaOct 1 08:11 ET

Express News | Ocean Biomedical's Scientific Co-founder Jonathan Kurtis Issued US Patent For PfGARP Malaria Antibody

BenzingaAug 27 08:03 ET

Express News | Ocean Biomedical Received Noncompliance Notice From Nasdaq

BenzingaAug 23 16:31 ET

12 Health Care Stocks Moving In Monday's After-Market Session

BenzingaJun 10 16:31 ET

Express News | Ocean Biomedical Receives Notice From Nasdaq That It Is Not In Compliance With Listing Rule

BenzingaMay 30 07:46 ET

Express News | Ocean Biomedical, Inc. Announces Receipt of Notice From Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

ReutersMay 30 07:44 ET

Express News | Ocean Biomedical Granted Patent Allowance For Malaria Antibodies

BenzingaMay 16 08:02 ET

Express News | Ocean Biomedical, Inc. (Nasdaq: Ocea) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease

ReutersMay 16 08:01 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

BenzingaMay 14 16:31 ET